U.S. FDA staff raises no new concerns with Moderna's coronavirus vaccine
FDA staff says the vaccine is effective without any specific safety issues in adults over the age of 18
Full Article
U.S. FDA staff raises no new concerns with Moderna's coronavirus vaccine
Haaretz
0 shares
1 views
You might like
Related news coverage
America’s Deadliest Year, In Numbers – OpEd
Eurasia Review
This year, more than any other in recent memory, we experienced a public health emergency in the shape of charts and data which..
-
Dow climbs to record close on coronavirus vaccine and economic stimulus benefit hopes
Proactive Investors
-
Dow Jones climbs to record close on coronavirus vaccine and economic stimulus benefit hopes
Proactive Investors
-
US stocks hold firm on coronavirus vaccine and economic stimulus benefit hopes
Proactive Investors
-
COVID-19 dominates 2020 for biotech sector … and everyone else
Proactive Investors
Advertisement
More coverage
NA Proactive news snapshot: Mirasol Resources, BetterLife Pharma, Victory Resources, Todos Medical ...
Proactive Investors
Mirasol Resources Ltd (CVE:MRZ) (OTCPINK:MRZLF) (FRA:M8R) said Wednesday it intends to remain independent and focused on its..